Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection

• Elvira Baos,
• Alberto Delgado-Iribarren,
• Silvia O´Connor,
• Ignacio Bardón,
• Mar Alvaréz,
• Iciar Rodríguez-Avial,
• Esther Culebras

Affiliations

Elvira Baos

Department of Clinical Microbiology, IML and IdISSC, Hospital Clínico San Carlos, Madrid, Spain

Alberto Delgado-Iribarren

Department of Clinical Microbiology, IML and IdISSC, Hospital Clínico San Carlos, Madrid, Spain; Department of Medicine, Facultad de Medicina, Universidad Complutense, Madrid, Spain

Silvia O´Connor

Occupational Health and Safety Service. Hospital Clínico San Carlos, Madrid, Spain

Ignacio Bardón

Occupational Health and Safety Service. Hospital Clínico San Carlos, Madrid, Spain

Mar Alvaréz

Department of Clinical Microbiology, IML and IdISSC, Hospital Clínico San Carlos, Madrid, Spain

Iciar Rodríguez-Avial

Department of Clinical Microbiology, IML and IdISSC, Hospital Clínico San Carlos, Madrid, Spain; Department of Medicine, Facultad de Medicina, Universidad Complutense, Madrid, Spain

Esther Culebras

Department of Clinical Microbiology, IML and IdISSC, Hospital Clínico San Carlos, Madrid, Spain; Department of Medicine, Facultad de Medicina, Universidad Complutense, Madrid, Spain; Corresponding author: Esther Culebras. Microbiology Department, Hospital Clinico San Carlos, C/ Martin Lagos s/n. 28040-Madrid, Spain.